Casey R. Tak

The Cost of Control: Financial and Administrative Burdens of Limited Distribution Network Changes in Cystic Fibrosis

Brittany A. Wright, Cameron J. McKinzie, Charissa W. Kam, Casey R. Tak et autres

BACKGROUND: The clinical impact of pharmacists and pharmacy technicians on the care of people with cystic fibrosis (pwCF) has been well documented within the literature, including medication access, reduction of hospitalizations, and consolidation of pharmaceutical delivery for pwCF with complex medication regimens. …

us (code pays fourni par la source)

Co-creating and disseminating substance use and vaping educational videos, question prompt lists, and other resources in partnership with community organizations and youth in Western North Carolina

McKenna Knock, Jeremy Lowery, Casey R. Tak, Abena A. Adjei et autres

us (code pays fourni par la source)

Impact of Early Intervention on Motor Milestone Achievement in Spinal Muscular Atrophy: Insights from Cure SMA Survey Data

Kendra A. K. Lawrence, Lisa T. Belter, Mary Curry, Casey R. Tak et autres

INTRODUCTION: There is a paucity of real-world evidence on the impact of early treatment as well as polytherapy use on advanced motor milestone achievement in children with spinal muscular atrophy (SMA) with ≤ 2 survival motor neuron 2 gene (SMN2) copies. The …

us, au (code pays fourni par la source)

Impact of Excessive Postural Tachycardia on Disability in Youth with Orthostatic Intolerance

Kirti Sivakoti, Olivia Parnell, Corinne Espinoza, Casey R. Tak et autres

OBJECTIVE: To compare Functional Disability Inventory (FDI) between adolescents with chronic orthostatic intolerance (COI) and postural orthostatic tachycardia syndrome (POTS). STUDY DESIGN: This cross-sectional study included adolescents ≤19 years with orthostatic symptoms >3 months referred to a tertiary pediatric autonomic clinic (August …

us (code pays fourni par la source)

Parent–Child Agreement on the Functional Disability Inventory in Adolescents with Chronic Orthostatic Intolerance

Kirti Sivakoti, Olivia Parnell, Corinne Espinoza, Stanley Brewer et autres

us (code pays fourni par la source)

Treatment of opioid use disorder in pregnancy among individuals with and without co-occurring stimulant use disorder: A retrospective cohort study

Elizabeth M. Charron, Amanda A. Allshouse, Casey R. Tak, Kristine A. Campbell et autres

us (code pays fourni par la source)

Psychotropic deprescribing across different prescribing professions in New Mexico and Louisiana

Phillip M. Hughes, Joshua D. Niznik, Robert E. McGrath, Casey R. Tak et autres

This study aimed to assess differences in the rates of deprescribing between prescribing psychologists, psychiatrists, and primary care physicians. MarketScan private insurance claims were used to develop a longitudinal active-comparator, prevalent-user cohort of patients who were treated with a psychotropic medication from …

us (code pays fourni par la source)

Response to “Critical Appraisal of Health Care Resource Utilization and Health Care Costs Among Digital Weight Loss Intervention Participants and Nonparticipants”

Casey R. Tak, Meaghan McCallum, Jessica L. Morse

We thank the authors Khan, Kayani, and Alokozay for their thoughtful review of our study examining healthcare resource utilization (HRU) among individuals engaged with Noom compared to non-Noom controls [1].

us (code pays fourni par la source)

Sustainability of PharmD Research Projects After a Switch from a Required to an Elective Program.

Craig P. Henchey, Daniel M. Witt, Chia Jie Tan, Casey R. Tak et autres

us (code pays fourni par la source)

Mental health diagnosis and medication changes after initiation of elexacaftor/tezacaftor/ivacaftor

Cameron J. McKinzie, Casey R. Tak, Stephanie R. Duehlmeyer, S. Foushee et autres

RATIONALE: Elexacaftor/tezacaftor/ivacaftor (ETI) has been associated with varied effects on mental health (MH) in people with cystic fibrosis (PwCF). Currently published literature has focused primarily on MH diagnoses/symptoms with ETI as opposed to associated pharmacotherapy. OBJECTIVES: We sought to evaluate the effect …

us (code pays fourni par la source)

793 CF-HEAR: Implementation of a tablet-based audiology screening protocol in people with cystic fibrosis

C. McKinzie, Casey R. Tak, Ashley Buige, S. Duehlmeyer et autres

470 Financial & administrative impacts on people with cystic fibrosis, pharmacists, and pharmacy technicians at CFF-accredited care centers following changes in pharmaceutical limited distribution network

Breanna Wright, Charissa W. Kam, Moritz Z. Kayser, Lynnsey M. Knockel et autres